ADXN

Addex Therapeutics Ltd American Depositary Shares

HealthcareBiotechnologySwitzerlandNASDAQ

$6.85

-0.72%today

MKT CAP

$8M

-2.8% · 1Y

Full Financials

Trailing P/E-

Forward P/E-140.2x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-97.4%

5y Revenue CAGR-49.3%

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership0.0%

Institutional Ownership0.1%

Short % of Float0.69%

Days to Cover1.3d

1 Week+6.2%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Top Holders

Holder	Type	% Held	Value	Δ Shares	As of
Morgan Stanley	institution	0.02%	$0.00B	+100.00%	2025-12-31
Rhumbline Advisers	institution	0.00%	$0.00B	+0.00%	2025-12-31
Gamma Investing LLC	institution	0.00%	$0.00B	+0.00%	2026-03-31
SBI Securities Co., Ltd.	institution	0.00%	$0.00B	+0.00%	2026-03-31

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
PTGX Protagonist Therapeutics Inc. Common Stock	$6.6B	5	-	-	-	-	-	-	0.00%
CELC Celcuity Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	0.00%
ACLX Arcellx Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	-
KYMR Kymera Therapeutics Inc. Common Stock	$7.0B	-	-	-	-	-27.1%	0%	5.23	0.00%
TECH Bio-Techne Corp Common Stock	$7.1B	36	72.7	24.4	-	-	-	-	63.00%
HALO Halozyme Therapeutics Inc. Common Stock	$7.9B	73	25.5	6.6	-	-	-	-	0.00%